Acute Immunological Profile and Prognostic Biomarkers of Persistent Joint Pain in Chikungunya Fever: A Systematic Review
- PMID: 39703607
- PMCID: PMC11650912
- DOI: 10.59249/RQYJ3197
Acute Immunological Profile and Prognostic Biomarkers of Persistent Joint Pain in Chikungunya Fever: A Systematic Review
Abstract
Chikungunya virus infection (CHIKV) increases the risk of persistent arthralgia; however, there is no consistent evidence regarding prognostic biomarkers of progression to chronic arthropathy. This systematic review provides an overview of currently available literature about the potential role of the acute immunologic response in predicting long-term joint pain in patients with a diagnosis of CHIKV. We searched for observational studies using the terms "chikungunya," "cytokines," "biomarkers," and "joint pain" in PubMed/MEDLINE, LILACS, Cochrane Library Plus, and SCOPUS databases, restricting to articles published in English and up to April 2024. PROSPERO registration number: CRD42021279400. Thirty-eight studies were selected for qualitative synthesis with a maximum duration from diagnosis to clinical evaluation of 60 months. The sample sizes ranged from 8 to 346 participants (age range: 0-90 years). We identified an immunologic profile during the acute phase of CHIKV that includes increased levels of proinflammatory cytokines (IFN-α, IFN-γ, IL-2R, IL-6, IL-7, and IL-8), anti-inflammatory cytokines (IL-1Ra and IL-4), chemokines (MCP-1, MIG, and IP-10) and growth factors (VEGF and G-CSF). Only one out of two studies reported differences in cytokine levels during the acute phase, predicting persistent joint pain at 20 months of follow-up. Also, persistence of anti-CHIKV IgG seemed to be a potential prognostic marker. The evidence suggests the existence of an inflammatory response in the acute phase of CHIKV that persists during its chronic phase; however, there is no unequivocal candidate set of biomarkers of progression toward long-term articular sequelae.
Keywords: Chikungunya fever; arthralgia; biomarkers; chronic pain; cytokines.
Copyright ©2024, Yale Journal of Biology and Medicine.
Figures
References
-
- Simon F, Javelle E, Cabie A, Bouquillard E, Troisgros O, Gentile G, et al. Société de pathologie infectieuse de langue francaise . French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Med Mal Infect. 2015. Jul;45(7):243–63. 10.1016/j.medmal.2015.05.007 - DOI - PubMed
-
- López Rodríguez MA. Evaluación de las manifestaciones reumatológicas y las alteraciones paraclínicas luego de dos años de la presentación de la infección por virus de chikungunya en un brote en el municipio de Capitanejo, Santander. [Tesis de Especialización en Medicina Interna]. Universidad Industrial de Santander; 2018.
-
- Rodriguez-Morales AJ, Gil-Restrepo AF, Ramírez-Jaramillo V, Montoya-Arias CP, Acevedo-Mendoza WF, Bedoya-Arias JE, et al. Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia. F1000 Res. 2016. Mar;5(360):360. 10.12688/f1000research.8235.1 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous